arrow
F

Farooq H. Sheikh

Georgetown University School of Medicine
H指数:20
被引数:4,026

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real World Adoption and Associated Outcomes of Aspirin Avoidance After HeartMate 3 Implantation: The PRAISE HM3 Study

Real World Adoption and Associated Outcomes of Aspirin Avoidance After HeartMate 3 Implantation: The PRAISE HM3 Study 心室辅助装置植入后阿司匹林避免使用的真实世界采用及关联结果:PRAISE HM3 研究

2026-10-120
OAAI
Continuous Vutrisiran Reduces Cardiovascular Events and Hospitalizations in Patients With Transthyretin Amyloidosis With Cardiomyopathy in the HELIOS-B One-Year Open Label Extension

连续注射Vutrisiran可降低伴心肌病的甲状腺素转运蛋白淀粉样变性患者的心血管事件和住院率:HELIO-B研究一年开放标签扩展研究

2026-10-110
OA
Mechanically Reducing Cardiac Preload With the preCARDIA System in Acutely Decompensated Heart Failure

使用preCARDIA系统机械性降低急性失代偿心力衰竭患者的心脏前负荷

2025-12-130
PRE
Withdrawal of aspirin in patients with left ventricular assist device treated with vitamin K antagonists: impact of anticoagulation quality in the randomized ARIES-HM3 trial

左心室辅助装置且接受维生素K拮抗剂治疗的患者停用阿司匹林:随机ARIES-HM3试验中抗凝质量的影响

2025-11-011
OA
Impact of pulmonary artery catheterization in patients with acute myocardial infarction cardiogenic shock

肺动脉导管插入术对急性心肌梗死合并心源性休克患者的影响

2025-09-010
PRE
Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-B

Vutrisiran对伴有心肌病的甲状腺素转运蛋白淀粉样变性患者心脏生物标志物的影响:来自HELIOS-B的研究

2025-08-040
OA
Heterogeneity in HeartMate 3 Implanting Center Infection Management Reveals Opportunities for Quality Improvement and Best Practice Initiatives during Left Ventricular Assist Device Support

HeartMate 3植入中心感染管理的异质性揭示了左心室辅助装置支持期间质量改进和最佳实践倡议的机会。

2025-07-280
OA
Risk Factors and Comorbidities Associated With Vitamin B 12 Deficiency in an Adult Population

维生素 B<sub>12</sub> 缺乏在成人人群中的危险因素和合并症

2025-07-280
OA